Leishmaniasis patients in Eastern Africa may soon benefit from a new drug set to be developed by collaboration of Novartis, one of the biggest pharmaceuticals company and the Drugs for … Read More
By Nathan Mulure – The history of resistance to antimalarials in Africa is not a happy one. At one time chloroquine was the leading recommended treatment against malaria.
By Andualem Sisay Gessesse – Novartis, a global healthcare company based in Switzerland, is set to introduce a new program to Ethiopia that aims to make affordable treatment of chronicle … Read More
The international political climate may be turning against globalization and threatening economic growth, but there is still a chance to channel money into sectors that can boost prosperity in poor … Read More